Clinical Trial Update: Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept [Phase 2]

View source ↗

Summary

Phase 2 trial update on intracoronary stenting with antithrombotic regimen targeting lesion platelet adhesion using Revacept in stable coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• Revacept (revacept)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Stable Coronary Artery Disease | Phase 2 | Status: COMPLETED